Radiation necrosis of the pons after radiotherapy for nasopharyngeal carcinoma: Diagnosis and treatment

Journal of Radiology Case Reports

Volumn 6, Issue 7, 2012, Pages 9-16

  DeSalvo, Matthew N ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Bevacizumab; Mr spectroscopy; Nasopharyngeal carcinoma; Pons; Radiation necrosis

Indexed keywords

BEVACIZUMAB;

ADULT; ARTICLE; CASE REPORT; CHEMORADIOTHERAPY; DIFFERENTIAL DIAGNOSIS; GLIOMA; HEMIPARESIS; HUMAN; MALE; NASOPHARYNX CARCINOMA; NUCLEAR MAGNETIC RESONANCE IMAGING; PHYSICAL EXAMINATION; PONS; PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA; RADIATION DOSE; RADIATION NECROSIS; SLURRED SPEECH; TOXOPLASMOSIS;

BEVACIZUMAB; MR SPECTROSCOPY; NASOPHARYNGEAL CARCINOMA; PONS; RADIATION NECROSIS;

ANGIOGENESIS INHIBITORS; ANTIBODIES, MONOCLONAL, HUMANIZED; CHEMORADIOTHERAPY, ADJUVANT; DIAGNOSIS, DIFFERENTIAL; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED; NASOPHARYNGEAL NEOPLASMS; NECROSIS; PONS; RADIATION INJURIES; TREATMENT OUTCOME;

EID: 84864491134     PISSN: None     EISSN: 19430922     Source Type: Journal    
DOI: 10.3941/jrcr.v6i7.1108     Document Type: Article

References (22)

1. Burger PC, Mahley MS Jr, Dudka L and Vogel FS. The morphologic effects of radiation administered therapeutically for intracranial gliomas: a postmortem study of 25 cases. Cancer. 1979;44(4):1256.PMID: 387205.
2. Van Tassel P, Bruner JM, Maor MH et al. MR of toxic effects of accelerated fractionation radiation therapy and carboplatin chemotherapy for malignant gliomas. AJNR. 1995 Apr;16(4):715-726.PMID: 7611028.
3. Kumar AJ, Leeds NE, Fuller GN et al. Malignant gliomas: MR imaging spectrum of radiation therapy- and chemotherapy-induced necrosis of the brain after treatment. Radiology. 2000 Nov;217(2):377-384.PMID: 11058631.
4. Offiah C and Hall E. Post-treatment imaging appearances in head and neck cancer patients. Clin Radiol. 2011 Jan;66(1):13-24.PMID: 21147294.
5. Chong VF, Fan YF and Mukherji SK. Radiation-induced temporal lobe changes: CT and MR imaging characteristics. AJR. 2000 Aug;175(2):431-436.PMID: 10915689.
6. Caroline I and Rosenthal MA. Imaging modalities in high- grade gliomas: Pseudoprogression, recurrence, or necrosis? J Clin Neuroscience. 2012 Feb 7. Epub ahead of printing.PMID: 22321359.
7. Barkovich AJ, Krischer J, Kun LE et al. Brain stem gliomas: a classification system based on magnetic resonance imaging. Pediatr Neurosurg. 1990-1991;16(2):73-83.PMID: 2132928.
8. Schwingel R, Reis F, Zanardi VA, Quieroz LS and França MC Jr. Central nervous system lymphoma: magnetic resonance imaging features at presentation. Arq Neuropsiquatr. 2012 Feb;70(2):97-101.PMID: 22311212.
9. Villringer K, Jäger H, Dichgans M et al. Differential diagnosis of CNS lesions in AIDS patients by FDG-PET. J Comput Assist Tomogr. 1995 Jul-Aug;19(4):532-536.PMID: 7622678.
10. Ogawa T, Kanno I, Hatazawa J et al. Methionine PET for follow-up of radiation therapy of primary lymphoma of the brain. Radiographics. 1994 Jan;14(1):101-110.PMID: 8128041.
11. De la Peña RC, Ketonen L and Villanueva-Meyer J. Imaging of brain tumors in AIDS patients by means of dual- isotope thallium-201 and technetium-99m sestamibi single- photon emission tomography. Eur J Nucl Med. 1998 Oct;25(10):1404-1411.PMID: 9818280.
12. Simone IL, Federico F, Tortorella C et al. Localised 1H- MR spectroscopy for metabolic characterisation of diffuse and focal brain lesions in patients infected with HIV. J Neurol Neurosurg Psychiatry. 1998 Apr; 64(4):516-523.PMID: 9576546.
13. Armstrong RW and Fung PC. Brainstem encephalitis (rhombencephalitis) due to Listeria monocytogenes: case report and review. Clin Infect Dis. 1993;16(5):689.PMID: 8507761.
14. Alper G, Knepper L and Kanal E. MR findings in listerial rhombencephalitis. AJNR. 1996 Mar; 17(3):593-596.PMID: 8881261.
15. Benito-Leon J, Alvarez-Linera J, Jimenez L and Valera M. Diagnostic usefulness of diffusion-weighted magnetic resonance imaging in listerial rhombencephalitis. Eur J Neurol. 2002 Nov;9(6):693-694.PMID: 12453092.
16. Sahin S, Arisoy AS, Topkaya AE and Karsidag S. Brain-stem listeriosis: a comparison of SPECT and MRI findings. MedGenMed. 2006;8(4):47. PMCID: PMC1868329.
17. Zagardo MT, Shanholtz CB, Zoarski GH and Rothman MI. Rhombencephalitis caused by adenovirus: MR imaging appearance. AJNR. 1998 Nov. 19:1901-3.PMID: 9874544.
18. Goto K, Sanefuji M, Kushara K et al. Rhombencephalitis and coxsackievirus A16. Emerg Infect Dis. 2009 Oct. 15(10):1689-1691. P MID: 198 6107 8.
19. Moragas M, Martinez-Yelamos S, Majos C, Fernandez-Viladrich P, Rubio F and Arbizu T. Rhombencephalitis: a series of 97 patients. Medicine (Baltimore). 2011 Jul;90(4):256-261.PMID: 21694648.
20. Gonzalez J, Kumar AJ, Conrad CA and Levin VA. Effect of bevacizumab on radiation necrosis of the brain. Int J Radiat Oncol Biol Phys. 2007; 67(2):323-326.PMID: 17236958.
21. Torcuator R, Zuniga R, Mohan YS et al. Initial experience with bevacizumab treatment for biopsy confirmed cerebral radiation necrosis. J Neurooncol. 2009 Aug;94(1):63-68.PMID: 19189055.
22. Levin VA, Bidaut L, Hou P et al. Randomized double- blind placebo-controlled trial of bevacizumab therapy for radiation necrosis of the central nervous system. Int J Radiat Oncol Biol Phys. 2011;79(5):1487.PMID: 20399573.